milk thistle silymarin high dose
Selected indexed studies
- Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. (Phytother Res, 2019) [PMID:31069872]
- Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. (Integr Cancer Ther, 2007) [PMID:17548790]
- Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. (Drug Metab Dispos, 2008) [PMID:17913795]
_Worker-drafted node — pending editorial review._
Connections
milk thistle silymarin high dose protects against
milk thistle silymarin high dose helps
Sources
- Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. (2019) pubmed
- Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. (2007) pubmed
- Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. (2008) pubmed
- In vivo efficacy study of milk thistle extract (ETHIS-094™) in STAM™ model of nonalcoholic steatohepatitis. (2014) pubmed
- Coadministration of milk thistle and indinavir in healthy subjects. (2003) pubmed
- Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients. (2012) pubmed
- Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis. (2013) pubmed
- Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells. (2011) pubmed
- Evaluation of 5-day In Vivo Rat Liver and Kidney With High-throughput Transcriptomics for Estimating Benchmark Doses of Apical Outcomes. (2020) pubmed
- Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. (2002) pubmed